retatrutide clinical trials status Reta trial data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 for metabolic health — targeting GLP-1, GIP First Retatrutide phase 3 data,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13











![GLP-1 Suitability Panel — At-Home Metabolic Test [Weight Insights]](https://cdn.shopify.com/s/files/1/0448/1033/8466/files/glp-1-1.jpg?v=1761798026)














